Julie Grant is a general partner at Canaan focused on forming and investing in biopharmaceutical companies, and serves on the National Cancer Advisory Board. She previously worked at Genentech across business development, management and commercialization of oncology products.
Julie Grant is a general partner at Canaan focused on forming and investing in biopharmaceutical companies, and serves on the National Cancer Advisory Board. She previously worked at Genentech across business development, management and commercialization of oncology products.
Career
General Partner at Canaan Partners until PresentNCNational Cancer Advisory Board Member at National Cancer Institute until Present
